Consensus Humana Inc.

Equities

HUM

US4448591028

Real-time Estimate Cboe BZX 11:33:11 2024-04-26 am EDT 5-day change 1st Jan Change
307.5 USD -1.25% Intraday chart for Humana Inc. -6.19% -32.73%

Evolution of the average Target Price on Humana Inc.

Price target over the last 5 years

History of analyst recommendation changes

1f5ee652bc4ce64da08ab0b700c7a93.Hg27J0g-0jofqK0mHk96xEw3aSNuf121epnuC0VpLLY.Ujr-SSBzkEBU_cR0b3oCoDZ9LWYqDAjQT--JeQAGS8JBW-pWClaaXkya9A~f812710eedd4f55dd1be91eba16b88ff
Deutsche Bank Adjusts Price Target on Humana to $341 From $355 MT
UBS Cuts Humana's Price Target to $326 From $334, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on Humana to $365 From $381 MT
Goldman Sachs Adjusts Price Target on Humana to $373 From $385 MT
RBC Cuts Price Target on Humana to $353 From $415, Keeps Outperform Rating MT
Cantor Fitzgerald Adjusts Price Target on Humana to $360 From $391 MT
Oppenheimer Adjusts Price Target on Humana to $370 From $415 MT
Stephens Adjusts Price Target on Humana to $350 From $395 MT
Bernstein Adjusts Price Target on Humana to $357 From $420 MT
TD Cowen Lowers Humana Price Target to $396 from $427 MT
Mizuho Adjusts Price Target on Humana to $385 From $400 MT
Jefferies Lowers Humana Price Target to $381 from $411 MT
Zacks Upgrades Humana to Neutral From Underperform MT
Truist Securities Adjusts Price Target on Humana to $355 From $400 MT
Wells Fargo Cuts Price Target on Humana to $350 From $413, Maintains Overweight Rating MT
Goldman Sachs Cuts Price Target on Humana to $385 From $450, Maintains Buy Rating MT
UBS Cuts Humana's Price Target to $334 From $370, Maintains Neutral Rating MT
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman... Our Logo
Raymond James Starts Humana With Market Perform Rating MT
Argus Downgrades Humana to Hold From Buy MT
That's good enough for investors Our Logo
ANALYST RECOMMENDATIONS : Chevron, McDonald's, Palantir, Sainsbury, Tesla... Our Logo
Wells Fargo Adjusts Price Target on Humana to $413 From $465, Keeps Overweight Rating MT
Goldman Sachs Cuts Price Target on Humana to $450 From $515, Keeps Buy Rating MT
Nephron Research Cuts Humana Price Target to $400 From $648, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
311.4 USD
Average target price
375.4 USD
Spread / Average Target
+20.55%
High Price Target
550 USD
Spread / Highest target
+76.62%
Low Price Target
326 USD
Spread / Lowest Target
+4.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Humana Inc.

UBS
Jefferies & Co.
Goldman Sachs
RBC Capital Markets
Cantor Fitzgerald
Oppenheimer
Stephens Inc.
Bernstein
TD Cowen
Mizuho Securities
Zacks Investment Research
Truist Securities
Wells Fargo Securities
Raymond James
Argus
Nephron Research
Deutsche Bank Securities
JPMorgan Chase
Morgan Stanley
SVB Securities LLC
Cowen
Credit Suisse
Loop Capital
BMO Capital
Barclays
SVB Leerink
Citigroup
Seaport Global Securities
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Consensus Humana Inc.